These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2727531)

  • 1. [Are paramedical means and methods justified in the treatment of breast carcinoma?].
    Hauser SP
    Schweiz Rundsch Med Prax; 1989 Apr; 78(17):498-506. PubMed ID: 2727531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Unproven treatments in cancerology].
    Schraub S; Helary JP
    Bull Cancer; 1991; 78(10):915-20. PubMed ID: 1768936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of use of complementary and alternative medicine in women with breast cancer.
    Lengacher CA; Bennett MP; Kip KE; Keller R; LaVance MS; Smith LS; Cox CE
    Oncol Nurs Forum; 2002; 29(10):1445-52. PubMed ID: 12432415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study.
    Schumacher K; Schneider B; Reich G; Stiefel T; Stoll G; Bock PR; Hanisch J; Beuth J
    Anticancer Res; 2003; 23(6D):5081-7. PubMed ID: 14981970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of alternative therapies among breast cancer outpatients compared with the general population.
    VandeCreek L; Rogers E; Lester J
    Altern Ther Health Med; 1999 Jan; 5(1):71-6. PubMed ID: 9893318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of drugs with questionable effectiveness and so-called natural preparations in oncology by patients. Results of a survey].
    Beaufort F; Drofenik M; Pleyer K
    Wien Med Wochenschr; 1988 Feb; 138(4):85-91. PubMed ID: 3376483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of complementary therapies by Australian women with breast cancer.
    Kremser T; Evans A; Moore A; Luxford K; Begbie S; Bensoussan A; Marigliani R; Zorbas H
    Breast; 2008 Aug; 17(4):387-94. PubMed ID: 18534852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer.
    Lengacher CA; Bennett MP; Kipp KE; Berarducci A; Cox CE
    Oncol Nurs Forum; 2003; 30(5):811-21. PubMed ID: 12949594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Compilation and brief summary of the documentation of unproven methods in cancer therapy of the American Cancer Society (ACS) from 1962 to 1985. Document No. 11 (the original of this document is in French)].
    Jallut O
    Schweiz Rundsch Med Prax; 1989 May; 78(18):524-31. PubMed ID: 2543049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer.
    Henderson JW; Donatelle RJ
    Altern Ther Health Med; 2004; 10(1):52-7. PubMed ID: 14727500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary and alternative medical treatment of breast cancer: a survey of licensed North American naturopathic physicians.
    Standish LJ; Greene K; Greenlee H; Kim JG; Grosshans C
    Altern Ther Health Med; 2002; 8(5):68-70; 72-5. PubMed ID: 12233805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Response To: Professor Cassileth's manuscript on "Alternative and Complementary Cancer Treatments," Featured in The Oncologist 1996;1:173-179.
    Quah TC
    Oncologist; 1996; 1(5):324-325. PubMed ID: 10388010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonhormonal alternatives for the management of early menopause in younger women with breast cancer.
    Bachmann GA
    J Natl Cancer Inst Monogr; 1994; (16):161-7. PubMed ID: 7999460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term breast cancer survivors' use of complementary therapies: perceived impact on recovery and prevention of recurrence.
    Hann D; Baker F; Denniston M; Entrekin N
    Integr Cancer Ther; 2005 Mar; 4(1):14-20. PubMed ID: 15695473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).
    Eggenschwiler J; von Balthazar L; Stritt B; Pruntsch D; Ramos M; Urech K; Rist L; Simões-Wüst AP; Viviani A
    BMC Complement Altern Med; 2007 May; 7():14. PubMed ID: 17493268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer.
    Adler SR; Fosket JR
    J Fam Pract; 1999 Jun; 48(6):453-8. PubMed ID: 10386489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of breast cancer in patients who use alternative therapies as primary treatment.
    Chang EY; Glissmeyer M; Tonnes S; Hudson T; Johnson N
    Am J Surg; 2006 Oct; 192(4):471-3. PubMed ID: 16978951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The deadliest delusion: unproven methods in the management of cancer.
    Brown HG
    Women Health; 1986; 11(3-4):165-78. PubMed ID: 3564497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effective treatment strategy in elderly breast cancer patients].
    Boér K
    Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.